Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes Introduction

DIABETES & METABOLISM

MASSON EDITEUR

1. Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08634, 16K09276, 16K08959]
2. Japan Agency for Medical Research and Development
3. 5th Annual Research Award Grant of Japanese Society of Anti-Aging Medicine
4. Takeda Science Foundation
5. Japan Research Foundation for Clinical Pharmacology
6. Kao Research Council for the Study of Healthcare Science
7. National Hospital Organization [H26-NHO-02]
8. Grants-in-Aid for Scientific Research [16K09276, 16H07498, 15K08634, 16K08959] Funding Source: KAKEN